Fourth shot “is critical” Pfizer CEO says as specialists monitor BA.2

A man in an open-collared suit addresses a woman in a matching chair.

Enlarge / Pfizer Chairman and CEO Dr. Albert Bourla speaks onstage on the 2022 SXSW Convention at JW Marriott Austin on March 14, 2022 in Austin. (credit score: Getty | Chris Saucedo)

Whereas US well being specialists intently monitor upticks of COVID-19 circumstances in Europe in addition to the worldwide rise of the omicron subvariant BA.2, Pfizer is renewing requires fourth doses of COVID-19 vaccine.

In an interview Sunday on CBS’ Face the Nation, Pfizer CEO Albert Bourla stated {that a} fourth dose—aka a second booster—is “needed.”

“The safety what we’re getting from the third [doses], it’s adequate—truly, fairly good for hospitalizations and deaths,” Dr. Bourla stated. However, “it isn’t that good towards infections” with omicron, and “it would not final very lengthy.” He reported that Pfizer is “working very diligently” to give you a brand new dose that may defend towards all variants and supply longer-lasting safety.

Learn eight remaining paragraphs | Feedback